DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

06855 ASCENTAGE-B

Trading Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind, Stock Connect HK Ind, Stock Connect HK MS, Stock Connect HK S I
Major Shareholders YANG Dajun & Associates (16.25%)
Takeda Pharmaceuticals Company Limited (6.51%)		 Sector Health Care & Biotechnology
Web Site http://www.ascentagepharma.com Tel (86 512) 8555-7777
Email IR@ascentage.com Fax N/A
Related Equities N/A
Principal Activities The Group is a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top